-
1
-
-
0037204196
-
Clinical practice. Antibiotic-Associated diarrhea
-
Bartlett JG. Clinical practice. Antibiotic-Associated diarrhea. N Engl J Med 2002; 346: 334-9.
-
(2002)
N Engl J Med
, vol.346
, pp. 334-339
-
-
Bartlett, J.G.1
-
2
-
-
33644523410
-
C lostridium diffi cile infection in patients discharged from US short-stay hospitals 1996-2003
-
McDonald LC, Owings M, Jernigan DB. C lostridium diffi cile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12: 409-15.
-
(2006)
Emerg Infect Dis
, vol.12
, pp. 409-415
-
-
McDonald, L.C.1
Owings, M.2
Jernigan, D.B.3
-
3
-
-
34447542645
-
Increasing prevalence and severity of Clostridium diffi cile colitis in hospitalized patients in the United States
-
Ricciardi R, Rothenberger DA, Madoff RD, et al. Increasing prevalence and severity of Clostridium diffi cile colitis in hospitalized patients in the United States. Arch Surg 2007; 142: 624-31.
-
(2007)
Arch Surg
, vol.142
, pp. 624-631
-
-
Ricciardi, R.1
Rothenberger, D.A.2
Madoff, R.D.3
-
4
-
-
84901373449
-
Managing Clostridium diffi cile in Inflammatory bowel disease (IBD)
-
Hashash JG, Binion DG. Managing Clostridium diffi cile in Inflammatory bowel disease (IBD). Curr Gastroenterol Rep 2014; 16: 393.
-
(2014)
Curr Gastroenterol Rep
, vol.16
, pp. 393
-
-
Hashash, J.G.1
Binion, D.G.2
-
5
-
-
44949261865
-
A national survey of the prevalence and impact of Clostridium diffi cile infection among hospitalized Inflammatory bowel disease patients
-
Nguyen GC, Kaplan GG, Harris ML, et al. A national survey of the prevalence and impact of Clostridium diffi cile infection among hospitalized Inflammatory bowel disease patients. Am J Gastroenterol 2008; 103: 1443-50.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 1443-1450
-
-
Nguyen, G.C.1
Kaplan, G.G.2
Harris, M.L.3
-
6
-
-
84925771391
-
Risk factors and management of refractory or recurrent Clostridium diffi cile infection in ileal pouch patients
-
Seril DN, Ashburn JH, Lian L, et al. Risk factors and management of refractory or recurrent Clostridium diffi cile infection in ileal pouch patients. Inflamm Bowel Dis 2014; 20: 2226-33.
-
(2014)
Inflamm Bowel Dis
, vol.20
, pp. 2226-2233
-
-
Seril, D.N.1
Ashburn, J.H.2
Lian, L.3
-
7
-
-
56249107224
-
Meta-Analysis to assess risk factors for recurrent Clostridium diffi cile infection
-
Garey KW, Sethi S, Yadav Y, et al. Meta-Analysis to assess risk factors for recurrent Clostridium diffi cile infection. J Hosp Infect 2008; 70: 298-304
-
(2008)
J Hosp Infect
, vol.70
, pp. 298-304
-
-
Garey, K.W.1
Sethi, S.2
Yadav, Y.3
-
8
-
-
67349239352
-
Recurrent Clostridium diffi cile infection: A review of risk factors, treatments, and outcomes
-
Johnson S. Recurrent Clostridium diffi cile infection: a review of risk factors, treatments, and outcomes. J Infect 2009; 58: 403-10.
-
(2009)
J Infect
, vol.58
, pp. 403-410
-
-
Johnson, S.1
-
9
-
-
84921767408
-
Diagnosis and treatment of Clostridium diffi cile in adults: A systematic review
-
Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium diffi cile in adults: a systematic review. JAMA 2015; 313: 398-408.
-
(2015)
JAMA
, vol.313
, pp. 398-408
-
-
Bagdasarian, N.1
Rao, K.2
Malani, P.N.3
-
10
-
-
84978221604
-
Lumnial toxin-binding agents for Clostridium diffi cile infection
-
e-pub ahead of print)
-
McCoy RM, Klick A, Hill S, et al. Lumnial toxin-binding agents for Clostridium diffi cile infection. J Pharm Pract 2016 (e-pub ahead of print).
-
(2016)
J Pharm Pract
-
-
McCoy, R.M.1
Klick, A.2
Hill, S.3
-
11
-
-
79151476267
-
Intravenous immunoglobulin for the treatment of Clostridium diffi cile infection: A review
-
Abougergi MS, Kwon JH. Intravenous immunoglobulin for the treatment of Clostridium diffi cile infection: a review. Dig Dis Sci 2011; 56: 19-26.
-
(2011)
Dig Dis Sci
, vol.56
, pp. 19-26
-
-
Abougergi, M.S.1
Kwon, J.H.2
-
12
-
-
84919774569
-
Probiotics for antibiotic-Associated diarrhea do we have a verdict?
-
Issa I, Moucari R. Probiotics for antibiotic-Associated diarrhea: do we have a verdict? World J Gastroenterol 2014; 20: 17788-95.
-
(2014)
World J Gastroenterol
, vol.20
, pp. 17788-17795
-
-
Issa, I.1
Moucari, R.2
-
13
-
-
79551527297
-
Fidaxomicin versus vancomycin for Clostridium diffi cile infection
-
Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for Clostridium diffi cile infection. N Engl J Med 2011; 364: 422-31.
-
(2011)
N Engl J Med
, vol.364
, pp. 422-431
-
-
Louie, T.J.1
Miller, M.A.2
Mullane, K.M.3
-
14
-
-
84884553359
-
Is C lostridium diffi cile associated with relapse of Inflammatory bowel disease? Results from a retrospective and prospective cohort study in the Netherlands
-
Masclee GM, Penders J, Jonkers DM, et al. Is C lostridium diffi cile associated with relapse of Inflammatory bowel disease? Results from a retrospective and prospective cohort study in the Netherlands. Inflamm Bowel Dis 2013; 19: 2125-31.
-
(2013)
Inflamm Bowel Dis
, vol.19
, pp. 2125-2131
-
-
Masclee, G.M.1
Penders, J.2
Jonkers, D.M.3
-
15
-
-
84923034822
-
Recurrent C lostridium diffi cile infection is associated with increased mortality
-
Olsen MA, Yan Y, Reske KA, et al. Recurrent C lostridium diffi cile infection is associated with increased mortality. Clin Microbiol Infect 2014; 21: 164-70.
-
(2014)
Clin Microbiol Infect
, vol.21
, pp. 164-170
-
-
Olsen, M.A.1
Yan, Y.2
Reske, K.A.3
-
16
-
-
84929250733
-
Risk factors for recurrent Clostridium diffi cile infection: A systematic review and meta-Analysis
-
Deshpande A, Pasupleti V, Thota P, et al. Risk factors for recurrent Clostridium diffi cile infection: a systematic review and meta-Analysis. Infect Control Hosp Epidemiol 2015; 00: 1-9.
-
(2015)
Infect Control Hosp Epidemiol
, pp. 1-9
-
-
Deshpande, A.1
Pasupleti, V.2
Thota, P.3
-
17
-
-
62949146399
-
Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium diffi cile infection
-
Hu MY, Katchar K, Kyne L, et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium diffi cile infection. Gastroenterology 2009; 136: 1206-14.
-
(2009)
Gastroenterology
, vol.136
, pp. 1206-1214
-
-
Hu, M.Y.1
Katchar, K.2
Kyne, L.3
-
18
-
-
0035915688
-
Association between antibody response to toxin A and protection against recurrent Clostridium diffi cile diarrhea
-
Kyne L, Warny M, Qamar A, et al. Association between antibody response to toxin A and protection against recurrent Clostridium diffi cile diarrhea. Lancet 2001; 357: 189-93.
-
(2001)
Lancet
, vol.357
, pp. 189-193
-
-
Kyne, L.1
Warny, M.2
Qamar, A.3
-
19
-
-
0028089161
-
Human antibody response to Clostridium diffi cile toxin A in relation to clinical course of infection
-
Warny M, Vaerman JP, Avesani V, et al. Human antibody response to Clostridium diffi cile toxin A in relation to clinical course of infection. Infect Immun 1994; 62: 384-9.
-
(1994)
Infect Immun
, vol.62
, pp. 384-389
-
-
Warny, M.1
Vaerman, J.P.2
Avesani, V.3
-
20
-
-
84899796356
-
Risk estimation for recurrent Clostridium diffi cile infection based on clinical factors
-
D?Agostino RB, Collins SH, Pencina KM, et al. Risk estimation for recurrent Clostridium diffi cile infection based on clinical factors. Clin Infect Dis 2014; 58: 1386-93.
-
(2014)
Clin Infect Dis
, vol.58
, pp. 1386-1393
-
-
D'Agostino, R.B.1
Collins, S.H.2
Pencina, K.M.3
-
21
-
-
36549001139
-
The prevalence and geographic distribution of Crohn?s disease and ulcerative colitis in the United States
-
Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn?s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007; 5: 1424-9.
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 1424-1429
-
-
Kappelman, M.D.1
Rifas-Shiman, S.L.2
Kleinman, K.3
-
22
-
-
84876384416
-
Risk factors and outcome of PCR-detected Clostridium diffi cile infection in ileal pouch patients
-
Li Y, Qian J, Queener E, et al. Risk factors and outcome of PCR-detected Clostridium diffi cile infection in ileal pouch patients. Inflamm Bowel Dis 2013; 19: 397-403.
-
(2013)
Inflamm Bowel Dis
, vol.19
, pp. 397-403
-
-
Li, Y.1
Qian, J.2
Queener, E.3
-
23
-
-
84923922666
-
The impact of proton pump inhibitors on the human gastrointestinal microbiome
-
Freedberg DE, Lebwohl B, Abrams JA. The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med 2014; 34: 771-85.
-
(2014)
Clin Lab Med
, vol.34
, pp. 771-785
-
-
Freedberg, D.E.1
Lebwohl, B.2
Abrams, J.A.3
|